Emtricitabine tenofovir efavirenz

Results: 142



#Item
1BMS_Gilead_Logo_FINAL.eps

BMS_Gilead_Logo_FINAL.eps

Add to Reading List

Source URL: packageinserts.bms.com

Language: English - Date: 2016-03-03 11:54:31
2Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section

Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic name: efaviren

Add to Reading List

Source URL: packageinserts.bms.com

Language: English - Date: 2016-02-18 16:31:16
3This is an electronically controlled document. User is responsible to verify and use the current revision.  GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

Add to Reading List

Source URL: gilead.com

Language: English - Date: 2013-02-25 18:48:52
4HIGHLIGHTS OF PRESCRIBING INFORMATION   New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

HIGHLIGHTS OF PRESCRIBING INFORMATION  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2013-10-28 13:55:09
5Microsoft Word - FPC QHP Policy Guide Febdoc

Microsoft Word - FPC QHP Policy Guide Febdoc

Add to Reading List

Source URL: fairpricingcoalition.org

Language: English - Date: 2014-02-05 17:34:29
6Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia

Add to Reading List

Source URL: shionogi616.tew-staging.com

Language: English - Date: 2014-11-03 11:26:18
7Clinical Commissioning Policy Statement: Stribild® for the treatment of HIV-1 infection in adults September 2013 Reference: NHS ENGLAND

Clinical Commissioning Policy Statement: Stribild® for the treatment of HIV-1 infection in adults September 2013 Reference: NHS ENGLAND

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2013-09-24 07:53:01
8

PDF Document

Add to Reading List

Source URL: www.afao.org.au

Language: English - Date: 2014-04-29 19:53:59
9AETC_Logo_trnsp_nkgrnd-bw

AETC_Logo_trnsp_nkgrnd-bw

Add to Reading List

Source URL: www.amc.edu

Language: English - Date: 2015-03-20 17:38:35
10

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:23